Pharmacological options for advanced cancer patients with loss of appetite and weight.

Item

http://www.wikidata.org/entity/Q36828134

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Pharmacological options for advanced cancer patients with loss of appetite and weight.

@en

type

Item

label

Pharmacological options for advanced cancer patients with loss of appetite and weight.

@en

prefLabel

Pharmacological options for advanced cancer patients with loss of appetite and weight.

@en

P1476

Pharmacological options for advanced cancer patients with loss of appetite and weight.

@en

P2093

Aminah Jatoi

http://www.w3.org/2001/XMLSchema#string

Deepti Behl

http://www.w3.org/2001/XMLSchema#string

P2860

Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial

A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.

Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study.

Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass.

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial.

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.

Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C

Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia.

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

P304

1085-1090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.8.1085

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17516872

http://www.w3.org/2001/XMLSchema#string

P921

appetite